Showing 591-600 of 4087 results for "".
Acne and Rosacea: Dr. Harper
https://practicaldermatology.com/programs/practical-dermatology/acne-and-rosacea-dr-harper/32686/Julie Harper, MD, summarizes her presentation during the "Update 2025: Acne and Rosacea" session at Maui Derm 2025, which focused on spironolactone, oral contraceptives, and topical clascoterone.Experts React to Latest Benzene Analysis
https://practicaldermatology.com/videos/dermwire-tv/experts-react-to-latest-benzene-analysis/29810/In this week's DermwireTV, Practical Dermatology Editorial Board members provide their thoughts on the recent analysis examining benzene concentrations in BPO products; Johnson & Johnson seeks new indications for IL-23 inhibitor Tremfya; and the founder and CEO of Terns discusses plans to improvPart 5, 1726 nm lasers: Differences between the AviClear laser (sapphire skin cooling and smart sensors) and the Accure laser (‘tube type’ cooling)
https://practicaldermatology.com/videos/scientifically-speaking/1726-nm-lasers-five-dermatologists-discuss-the-lasers-benefits-and-drawbacks-for-treating-acne-and-other-skin-conditions/24343/Chapter 5 of 7: David Goldberg, MD, from New York, Emil Tanghetti, MD, from Sacramento, Jordan Wang, MD, from Philadelphia and New York and Naz Saedi, MD, from Philadelphia talk about the differences between the AviClear laser (sapphire skin cooling and smart sensors) and the Accure laser (‘tube typPart 7, 1726 nm lasers: When a patient doesn’t improve: Doctors discuss “pearls” of wisdom
https://practicaldermatology.com/videos/scientifically-speaking/1726-nm-lasers-five-dermatologists-discuss-the-lasers-benefits-and-drawbacks-for-treating-acne-and-other-skin-conditions/24345/Chapter 7 of 7: David Goldberg, MD, from New York, Emil Tanghetti, MD, from Sacramento, Jordan Wang, MD, from Philadelphia and New York and Naz Saedi, MD, from Philadelphia talk about when a patient doesn’t improve: Doctors discuss “pearls” of wisdom.What Could Go Wrong with Fillers?
https://practicaldermatology.com/conferences/maui-derm-2024/what-could-go-wrong-with-fillers/20253/Joel L. Cohen, MD, explains the importance of understanding “what lies beneath” in order to more accurately evaluate post-procedure reactions and know how and when to intervene.What’s New With Neuromodulators?
https://practicaldermatology.com/conferences/maui-derm-2024/whats-new-with-neuromodulators/20252/Joel L. Cohen, MD, discusses the currently available neuromodulators as well as what’s on the radar, including ready-to-use liquid toxins and more.The Secret Sauce for Managing AD
https://practicaldermatology.com/conferences/scale-2023/the-secret-sauce-for-managing-ad/20190/James Del Rosso, DO, discusses new and upcoming therapies for atopic dermatitis including monoclonal antibodies and JAK inhibitors.DermWireTV: ASDS Meeting Highlights; Daxxify Data; PA Week
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-asds-meeting-highlights-daxxify-data-pa-week/20147/ASDS speakers address aesthetic advancements, skin cancer, and DEI with Joel L. Cohen, MD, Sherrif Ibrahim, MD, and Jeanine Downie, MD. On the heels of FDA approval of Revance’s Daxxify, data published in the Aesthetic Surgery Journal demonstrate the efficacy of DaxibotulinumtoxinA fAdvanced Laser Techniques from Cosmetic Surgery Forum 2019
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/advanced-laser-techniques-1/20125/What are the most promising energy-based options in laser technology. CSF faculty members, Jill Waibel, MD, Neil Sadick, MD, Manjula Jegasothy, MD, an Barry Lycka, MD offer fresh takes on the device field and share tips for optimizing outcomes.DermWireTV: PCA to Space Station; ASDS Pandemic Data; LaRoche-Posay, GW Partnership
https://practicaldermatology.com/topics/practice-management/dermwiretv-pca-to-space-station-asds-pandemic-data-laroche-posay-gw-partnership/20059/The "Great Resignation" forcing some dermatology practices to operate with reduced staffing is just one of the lingering impacts of the COVID-19 pandemic on practices, according to results of a survey by the American Society for Dermatologic Surgery. PCA skin is sending the first-ever private sector